Publications
Detailed Information
Integration of mesenchymal stem cells with nanobiomaterials for the repair of myocardial infarction
Cited 28 time in
Web of Science
Cited 33 time in Scopus
- Authors
- Issue Date
- 2015-12
- Publisher
- Elsevier BV
- Citation
- Advanced Drug Delivery Reviews, Vol.95, pp.15-28
- Abstract
- The integration of nanobiomaterials with stem cells represents a promising strategy for the treatment of myocardial infarction. While stem cells and nanobiomaterials each demonstrated partial success in cardiac repair individually, the therapeutic efficacy of the clinical settings for each of these has been low. Hence, a combination of nanobiomaterials with stem cells is vigorously studied to create synergistic effects for treating myocardial infarction. To date, various types of nanomaterials have been incorporated with stem cells to control cell fate, modulate the therapeutic behavior of stem cells, and make them more suitable for cardiac repair. Here, we review the current stem cell therapies for cardiac repair and describe the combinatorial approaches of using nanobiomaterials and stem cells to improve therapeutic efficacy for the treatment of myocardial infarction. (C) 2015 Elsevier B.V. All rights reserved.
- ISSN
- 0169-409X
- Files in This Item:
- There are no files associated with this item.
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.